Antibacterials, Women's Health
Silotrif M 25mg Tablet
SKU: SILOTRIF-M-25MG-TABLET
Active Pharmaceutical Ingredient
MIRABEGRON,SILODOSIN
Product Information
Silotrif M 25mg Tablet combines the active constituents Mirabegron and Silodosin, offering dual-action therapeutic benefits. Mirabegron belongs to the pharmacological class of beta-3 adrenergic agonists and is primarily indicated for managing overactive bladder symptoms. Silodosin, an alpha-1 adrenergic blocker, is used for treating urinary retention caused by benign prostatic hyperplasia (BPH). Together, these molecules target urinary health, alleviating discomfort caused by urinary disorders. Silotrif M 25mg Tablet is effective for adults with conditions requiring relaxation of bladder muscles and improved urine flow. While safe for most patients, it is crucial to follow dosage instructions to minimise potential side effects. Contraindications include severe liver or kidney impairments, uncontrolled hypertension, or hypersensitivity to any ingredient. Always consult your doctor for personalised advice.
• Overactive bladder symptoms such as frequent or urgent urination.
• Urinary retention or difficulty due to benign prostatic hyperplasia (BPH).
• Relief of bladder muscle overactivity in specific medical conditions.
• Urinary retention or difficulty due to benign prostatic hyperplasia (BPH).
• Relief of bladder muscle overactivity in specific medical conditions.
The therapeutic action of Silotrif M 25mg Tablet stems from its dual mechanisms. Mirabegron works by relaxing bladder muscles, enabling the bladder to store more urine and reducing urgency and frequency. Silodosin eases the muscles of the prostate and bladder neck, enhancing urine flow in patients with BPH.
Common side effects
• Severe allergic reactions (rash, swelling, difficulty breathing)
• Elevated blood pressure
• Urinary retention
• Elevated blood pressure
• Urinary retention
• Breast Feeding: Safety during breastfeeding is not established. Avoid use or consult a healthcare provider.
• Alcohol: Avoid alcohol consumption to prevent enhanced dizziness or drowsiness.
• Liver: Avoid in severe liver impairment as it may increase adverse effects.
• Lungs: Patients with severe respiratory conditions should exercise caution due to potential side effects.
• Driving: May cause dizziness or blurred vision; avoid driving if affected.
• Pregnancy: Limited data on use during pregnancy. Not recommended unless benefits outweigh risks.
• Alcohol: Avoid alcohol consumption to prevent enhanced dizziness or drowsiness.
• Liver: Avoid in severe liver impairment as it may increase adverse effects.
• Lungs: Patients with severe respiratory conditions should exercise caution due to potential side effects.
• Driving: May cause dizziness or blurred vision; avoid driving if affected.
• Pregnancy: Limited data on use during pregnancy. Not recommended unless benefits outweigh risks.
DISCOVER MORE
Related Products
BHARAT SERUMS & VACCINES LTD
Hucog-R 6500 IU Injection
BIOKINDLE LIFESCIENCES PVT LTD
Ketograce Bix
ABBOTT
Zombistin 4.5MIU Injection
MSD PHARMACEUTICALS PVT LTD
Zienam 500mg Injection
INTAS PHARMACEUTICALS LTD
Zilias 2000mg/500mg Injection
ARISTO PHARMACEUTICALS PVT LTD
Zidovance 2.5gm Injection
CELON LABORATORIES LTD
Zevtaz 2gm Injection
PFIZER LTD
